Digital therapeutics in oncology

Thought Leadership

Digital Therapeutics in Oncology (PART ONE): Advancing Outcomes Design

The digital health market is flooded with direct-to-consumer health and wellness applications. Digital health is a broad category that includes digital therapeutics (DTx)…

Download part I

With DTx in oncology showing great promise, we have outlined the current state of development, emerging applications, future trends, and strategies. In Part 1: Advancing Outcomes Design, we take a look at these new treatments from the clinical perspective. Our experts conducted a trend analysis of 12 marketed DTx solutions in oncology to understand its application areas or use cases. We also identified the four factors driving DTx in oncology: the complexity of the patient journey, the shift to remote treatment, personalised care, and holistic care.

In Part 2: Innovation Models, we take a deep dive into the evaluation criteria for Digital Therapeutics in Oncology. Our experts explore business questions that can stimulate innovation discovery and implementation. New revenue streams are on the horizon, primed to transform the sector for years to come.